Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Antoxerene
company
About
Antoxerene, Inc. is a pharmaceutical company
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
This is a pharmaceutical company that uses proprietary next generation screening technology to identify small molecule drugs for pathways of aging. It is an affiliate of Ichor Therapeutics. Antoxerene is eager to engage collaborators in industry and academia who share its vision of delivering next generation therapies for the illnesses of aging.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.50M
Antoxerene has raised a total of
$1.50M
in funding over 2 rounds. Their latest funding was raised on
Aug 28, 2017 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 28, 2017 | Seed | $1.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Antoxerene is funded by 1 investors.
Grapeseed.Bio
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Grapeseed.Bio
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
